Adenovirus hepatitis presenting as tumoral lesions in an immunocompromised patient

2014, Número 6

Ann Hepatol 2014; 13 (6)

Putra J, Suriawinata AA

Cómo citar este artículo

Idioma: Ingles.
Referencias bibliográficas: 5
Paginas: 827-829
Archivo PDF: 156.39 Kb.

RESUMEN

Sin resumen

REFERENCIAS (EN ESTE ARTÍCULO)

Iyer A, Mathur R, Deepak BV, Sinard J. Fatal adenoviral hepatitis after rituximab therapy. Arch Pathol Lab Med 2006; 130: 1557-60. Figure 2. Biopsy of one of the lesions showed hepatocytes with enlarged and dark smudge cells which were characteristic of adenovirus infections, H&E (x 200). Figure 3. Diffuse positive immunostaining for adenovirus antibody confirmed the diagnosis, adenovirus antibody (x 200). 829 Adenovirus hepatitis presenting as tumoral lesions. , 2014; 13 (6): 827-829
Ronan BA, Agrwal N, Carey EJ, De Petris G, Kusne S, Seville MT, Blair JE, et al. Fulminant hepatitis due to adenovirus. Infection 2014; 42: 105-11.
Wang WH, Wang HL. Fulminant adenovirus hepatitis following bone marrow transplantation. Arch Pathol Lab Med 2003; 127: 246-8.
Mortele KF, Segatto E, Ros PR. The infected liver: radiologic- pathologic correlation. Radiographics 2004; 4: 937-55.
Suriawinata AA, Thung SN. Acute and chronic hepatitis. Semin Diagn Pathol 2006; 23: 132-48.